Physical characterization and osteogenic activity of the quaternized chitosan-loaded PMMA bone cement
Source abstract
Abstract
Gentamicin-loaded polymethylmethacrylate (PMMA), widely used for primary cemented arthroplasty and revision surgery for preventing or treating infections, may lead to the evolution of antibiotic-resistant bacteria and dysfunction of osteogenic cells, which further influence the osteointegration of bone cement. In a previous study, we reported that a new quaternized chitosan derivative (hydroxypropyltrimethyl ammonium chloride chitosan, HACC) that was loaded into PMMA significantly inhibited the formation of biofilms caused by methicillin-resistant Staphylococcus strains. In the present study, we further investigated the surface morphology, hydrophilicity, apatite formation ability and osteogenic activity of HACC-loaded PMMA. Chitosan-loaded PMMA, gentamicin-loaded PMMA and PMMA without antibiotic were also investigated and compared. The results showed that, compared to other PMMA-based cements, HACC-loaded PMMA had improved properties such as a lower polymerization temperature, prolonged setting time, porous structures after immersion in phosphate-buffered saline, higher hydrophilicity, more apatite formation on the surface after immersion in simulated body fluid, and better attachment and spreading of the human-marrow-derived mesenchymal stem cells. We also found better stem cell proliferation, osteogenic differentiation, and osteogenesis-associated genes expression on the surface of the HACC-loaded PMMA compared to the gentamicin-loaded PMMA. Therefore, this new anti-infective bone cement had improved physical properties and osteogenic activity, which may lead to better osteointegration of the bone cement in cemented arthroplasty.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Orthopedic Infections and Treatments · Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Osteomyelitis in long bones10.2106/00004623-200410000-00028 ↗
2. Local antibiotic therapy in the treatment of open fractures and osteomyelitis10.1097/01.blo.0000143571.18892.8d ↗
3. The treatment of chronic osteomyelitis with a biodegradable antibiotic-impregnated implant10.1177/230949900201000110 ↗
4. Treatment of osteomyelitis and repair of bone defect by degradable bioactive borate glass releasing vancomycin10.1016/j.jconrel.2009.06.012 ↗
5. Resent progress in inorganic and composite coating with bactericidal capability for orthopaedic applications10.1016/j.nano.2010.10.005 ↗
6. Management of deep infection of total hip replacement10.1302/0301-620X.63B3.7021561 ↗
7. Local antibiotic delivery vehicles in the treatment of musculoskeletal infection10.1097/01.blo.0000175713.30506.77 ↗
8. Antibiotic-loaded bone cement in orthopaedic surgery10.1016/S1297-319X(03)00002-2 ↗
9. Backgrounds of antibiotic-loaded bone cement and prosthetic related infection10.1016/S0142-9612(03)00554-4 ↗
10. Polymethylmethacrylate: properties and contemporary uses in orthopaedics10.5435/00124635-201005000-00006 ↗
11. Prophylactic use of antibiotic bone cement: an emerging standard--in the affirmative10.1016/j.arth.2004.03.005 ↗
12. In vitro study of the efficacy of acrylic bone cement loaded with supplementary amounts of gentamicin effect on mechanical properties, antibiotic release, and biofilm formation10.1080/17453670710014545 ↗
13. Treatment of chronic osteomyelitis by necrectomy and gentamicin-PMMA beads10.1097/00003086-198109000-00028 ↗
14. The release of gentamicin from polymethylmethacrylate beads: an experimental and pharmacokinetic study10.1302/0301-620X.60B2.659478 ↗
15. Antibacterial coating systems10.1016/j.injury.2006.04.013 ↗
16. Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use10.1016/j.biomaterials.2010.05.005 ↗
17. Nanostructured materials for inhibition of bacterial adhesion in orthopedic implants: a minireview10.1177/039139880803100904 ↗
18. Bioactive titanium implant surfaces with bacterial inhibition and osteoblast function enhancement properties10.1177/039139880803100905 ↗
19. Pharmacokinetic study of gentamicin loaded cement in total hip replacements: comparative effects of varying dosage10.1302/0301-620X.66B2.6707051 ↗
20. Toxic effects of gentamicin on marrow-derived human mesenchymal stem cells10.1097/01.blo.0000229324.75911.c7 ↗
21. Gentamicin negatively influenced osteogenic function in vitro10.1007/s00264-006-0144-5 ↗
22. Gentamicin may have an adverse effect on osteogenesis10.1097/00005131-200303000-00010 ↗
23. Effect of various concentrations of antibiotics on osteogenic cell viability and activity10.1002/jor.21343 ↗
24. Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines10.1128/AAC.00729-05 ↗
25. Effect of polyhexanide and gentamicin on human osteoblasts and endothelial cells10.4414/smw.2007.11434 ↗
26. The in vitro effects of antibiotics on cell viability and gene expression of equine bone marrow-derived mesenchymal stromal cells
27. The effect of antibiotics on bone healing: current evidence10.1517/14740338.2011.589833 ↗
28. Adjustment of the antibacterial activity and biocompatibility of hydroxypropyltrimethyl ammonium chloride chitosan by varying the degree of substitution of quaternary ammonium10.1016/j.carbpol.2010.02.008 ↗
29. The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant staphylococcus10.1016/j.biomaterials.2011.09.084 ↗
30. The characteristics of a hydroxyapatite-chitosan-PMMA bone cement10.1016/j.biomaterials.2004.01.022 ↗
31. New aspects of the effect of size and size distribution on the setting parameters and mechanical properties of acrylic bone cements10.1016/0142-9612(96)82725-6 ↗
32. ISO 5833 Implants for surgery—acrylic resin cements. Switzerland: International Testing Organization; 2002.
33. How useful is SBF in predicting in vivo bone bioactivity?10.1016/j.biomaterials.2006.01.017 ↗
34. Proliferation and osteoblastic differentiation of human bone marrow-derived stromal cells on akermanite bioactive ceramics10.1016/j.biomaterials.2006.07.027 ↗
35. A novel route in bone tissue engineering: magnetic biomimetic scaffolds10.1016/j.actbio.2009.09.017 ↗
36. The influence of hierarchical hybrid micro/nano-textured titanium surface with titania nanotubes on osteoblast functions10.1016/j.biomaterials.2010.03.014 ↗
37. Bone bonding ability and handling properties of a titania–polymethylmethacrylate(PMMA) composite bioactive bone cement modified with a unique PMMA powder10.1016/j.actbio.2011.06.006 ↗
38. PMMA-based bone cements containing magnetite particles for the hyperthermia of cancer10.1016/j.actbio.2010.02.047 ↗
39. Human osteoblast adhesion on titanium alloy, stainless steel, glass and plastic substrates with same surface topography10.1023/A:1008992109670 ↗
40. Studies on the biocompatibility of materials: fibroblast reorganization of substratum-bound fibronectin on surfaces varying in wettability10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J ↗
41. The influence of substratum surface free energy on growth and spreading of human fibroblasts in the presence and absence of serum proteins10.1002/jbm.820200609 ↗
42. Attachment, spreading and short-term proliferation of human osteoblastic cells cultured on chitosan films with different degrees of acetylation10.1163/156856207780425068 ↗
43. An in vitro assessment of titanium functionalized with polysaccharides conjugated with vascular endothelial growth factor for enhanced osseointegration and inhibition of bacterial adhesion10.1016/j.biomaterials.2010.08.006 ↗
44. Mesenchymal stem cell proliferation and differentiation on an injectable calcium phosphate – chitosan composite scaffold10.1016/j.biomaterials.2009.01.022 ↗
45. Osteogenesis enhanced by chitosan (poly-n-acetyl-glucosamine) in vitro10.1902/jop.1996.67.11.1170 ↗
46. Stimulatory effect on bone formation exerted by a modified chitosan10.1016/0142-9612(94)90093-0 ↗